ClinicalTrials.Veeva

Menu

Affect Regulation Training for Pregnant Smokers

University at Buffalo (UB) logo

University at Buffalo (UB)

Status and phase

Completed
Phase 2
Phase 1

Conditions

Smoking Cessation

Treatments

Behavioral: health and lifestyle
Behavioral: affect regulation training

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01163864
R01DA021802 (U.S. NIH Grant/Contract)
Q607

Details and patient eligibility

About

Recent data indicate that approximately one-third of women of childbearing age smoke cigarettes, and 25-50% of women smoke during pregnancy. Cigarette smoking during pregnancy is a significant public health issue that can have profound effects on women's health and the health of their developing fetus. Smoking among pregnant women is associated with high levels of negative affect, which play a key role in the maintenance of smoking behavior and in difficulty quitting smoking during pregnancy. Despite the clear role of negative affect in the maintenance of smoking among pregnant women, and while this issue has received increased attention by clinicians and researchers, the investigators know of no smoking cessation intervention that combines coping skills and emotion regulation approaches to address the role of negative affect in smoking cessation. Smoking cessation treatment strategies that have demonstrated effectiveness in regular smokers have not translated into effective treatment strategies for pregnant women, particularly low-income pregnant women. The goal of this project is to develop and test an affect regulation smoking cessation intervention for low-income pregnant smokers.

The major aims of this project will be addressed in two sequential phases. In Phase 1, the investigators will develop two 8-session smoking cessation treatment manuals including: (a) Affect Regulation Training plus Cognitive-Behavioral Treatment (ART+CBT) and (b) a Health and Lifestyle plus Cognitive-Behavioral Treatment (HLS+CBT) control intervention. In Phase 2, the investigators will conduct a randomized clinical trial pilot study (Total N = 60) to compare the ART+CBT and HLS+CBT conditions on: a) the feasibility and acceptability of the interventions, (b) the impact of these interventions (ART+CBT and HLS+CBT) on smoking cessation rates at the end of the 8 treatment sessions (these occur approximately 2 months after treatment initiation) and at the 6-month post-quit date assessment (Session 2 is the quit date), (c) affect regulation skills, and (d) negative affect among pregnant smokers. The long-term goal of this proposed research is to increase smoking cessation rates among pregnant smokers, which would provide significant long-term health benefits for both mothers and their infants. This Stage 1 application will be used to generate feasibility and preliminary efficacy data, setting the stage for a Stage II efficacy trial.

Enrollment

77 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-40 years of age,
  • pregnancy involving single birth,
  • less than 24 weeks pregnant,
  • negative affect smoker,
  • smoking at least 1 cigarette per day,
  • no substance abuse diagnosis except marijuana,
  • no more than .50 ounces of ethanol per day,
  • can provide a collateral to verify smoking information.

Exclusion criteria

  • acute psychosis,
  • lack of familiarity with the English language.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

77 participants in 2 patient groups

affect regulation training
Experimental group
Treatment:
Behavioral: affect regulation training
health and lifestyle
Active Comparator group
Treatment:
Behavioral: health and lifestyle

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems